Investors Land BHVN Even Cheaper Than Its Secondary Stock Offering
December 14, 2018 at 10:05 AM EST
Looking back to 2 days ago, Biohaven Pharmaceutical Holding Co Ltd (BHVN) priced a 3,355,705 share secondary stock offering at $37.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
